The future of DNA synthesis holds immense promise, poised to redefine the boundaries of biotechnology and medicine. As we venture deeper into this era of genomic innovation, DNA synthesis is set to become faster, more accurate, and exponentially more affordable, enabling unprecedented advances in personalized medicine, synthetic biology, and bioengineering. As these technologies mature, we stand on the brink of a world where the ability to write DNA with precision and efficiency could unlock solutions to some of humanity's most pressing challenges, heralding a new age of scientific breakthroughs and applications.
In this talk, we speak with Matt Hill - Co-Founder & CEO @ Elegen, Tim Lu - Co-Founder & CEO @ Senti Bio, Jake Becraft - Co-Founder & CEO @ Stand Therapeutics, Patrick Boyle - Head of Codebase @ Ginkgo Bioworks, and Cristina Butterfield - Senior Director of Biochemistry and Characterization @ Metagenomi, to discuss their current bottlenecks within the space of DNA synthesis in the modern biotech stack and how companies like Elegen are advancing the next generation DNA supply.
Panel Moderated by: Chris Ghadban
Discussion Outline:
docs.google.co...
Thanks to the SynBioBeta Conference for hosting us :)
_______________________
Join BIOS Community 🎉
Become a member, continue the conversation, connect with like-minded Life Science innovators, access exclusive resources, & invite-only events…
Apply to Join -docs.google.co...
For More Interesting Content 💭
🦾 Website: www.bios.commu...
🧬 Podcast: open.spotify.c...
🧪 Medium: / bios
🩺 Twitter: / bios_community
🦠 LinkedIn: / bios-community
🧠 Substack: bioscommunity....
_______________________
BIOS: Nucleus of Life Science Innovation 🚀
Alix Ventures: Driving Patient Impact - Supporting Early Stage Startups Engineering Biology to Create Radical Advances in Human Health🌟
21 сен 2024
